Amylyx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 11.38 M | $154.64 M | 273.33% | 12.77% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 8.95 M | $121.66 M | 13.29% | 10.04% |
| BLACKROCK, INC. | 11/12/2025 | 7.14 M | $97.04 M | 29.59% | 8.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 6.82 M | $92.64 M | -22.54% | 7.65% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 6.24 M | $84.85 M | 5.05% | 7.00% |
| VANGUARD GROUP INC | 11/07/2025 | 5.27 M | $71.67 M | 17.25% | 5.92% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 4.60 M | $62.58 M | 41.23% | 5.17% |
| COMMODORE CAPITAL LP | 11/14/2025 | 4.08 M | $55.39 M | 100.00% | 4.57% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 3.36 M | $45.61 M | 100.00% | 3.76% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 2.79 M | $37.92 M | -38.49% | 3.13% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 2.54 M | $34.45 M | 100.00% | 2.85% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.42 M | $32.90 M | 91.37% | 2.72% |
| ALMITAS CAPITAL LLC | 11/17/2025 | 2.12 M | $28.85 M | 0.00% | 2.38% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 2.01 M | $27.32 M | 54.90% | 2.26% |
| MORGAN STANLEY | 11/14/2025 | 1.95 M | $26.50 M | 300.56% | 2.19% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 1.90 M | $25.82 M | 100.00% | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.81 M | $24.63 M | 7.07% | 2.03% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.76 M | $23.92 M | -18.52% | 1.97% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 1.70 M | $23.10 M | -15.00% | 1.91% |
| STATE STREET CORP | 11/14/2025 | 1.62 M | $22.03 M | 60.69% | 1.82% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 1.51 M | $20.55 M | 100.00% | 1.70% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.48 M | $20.06 M | 100.00% | 1.66% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.45 M | $19.71 M | 100.00% | 1.63% |
| UBS GROUP AG | 11/13/2025 | 1.40 M | $19.09 M | 12.06% | 1.58% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.37 M | $18.56 M | 121.35% | 1.53% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 1.20 M | $16.28 M | 100.00% | 1.34% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 1.11 M | $15.04 M | -4.11% | 1.24% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 935.68 K | $12.72 M | -68.11% | 1.05% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 900.00 K | $12.23 M | -26.53% | 1.01% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 866.20 K | $11.77 M | -28.12% | 0.97% |
| WOODLINE PARTNERS LP | 11/14/2025 | 845.29 K | $11.49 M | -29.58% | 0.95% |
| NORTHERN TRUST CORP | 11/14/2025 | 822.24 K | $11.17 M | 0.25% | 0.92% |
| INVESCO LTD. | 11/13/2025 | 810.64 K | $11.02 M | 38.13% | 0.91% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 750.60 K | $10.20 M | 139.66% | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 700.00 K | $9.51 M | 100.00% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 645.19 K | $8.77 M | 9.65% | 0.72% |
| BRAIDWELL LP | 11/14/2025 | 612.84 K | $8.33 M | 100.00% | 0.69% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 579.17 K | $7.87 M | -10.90% | 0.65% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 578.66 K | $7.86 M | 100.00% | 0.65% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 509.78 K | $6.94 M | 36.40% | 0.57% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 500.00 K | $6.80 M | 100.00% | 0.56% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 499.76 K | $6.79 M | 0.00% | 0.56% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2025 | 437.39 K | $5.94 M | 100.00% | 0.49% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 436.16 K | $5.93 M | -40.44% | 0.49% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 429.52 K | $5.84 M | -4.93% | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 417.77 K | $5.68 M | -72.37% | 0.47% |
| BARCLAYS PLC | 11/12/2025 | 414.11 K | $5.63 M | 217.88% | 0.46% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 367.33 K | $4.99 M | -35.45% | 0.41% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 333.26 K | $4.53 M | 100.00% | 0.37% |
| ALPHA WAVE GLOBAL, LP | 11/13/2025 | 327.31 K | $4.45 M | 18.66% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amylyx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 202 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FMR LLC: 11.38 M
PERCEPTIVE ADVISORS LLC: 8.95 M
BlackRock, Inc.: 7.14 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 6.82 M
TCG Crossover Management, LLC: 6.24 M
VANGUARD GROUP INC: 5.27 M
123.09% of Amylyx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 113.91 M shares in the last 24 months. This purchase volume represents approximately $1.62 B in transactions.